GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Analysis AS (XSAT:GEAN) » Definitions » Beginning Cash Position

Genetic Analysis AS (XSAT:GEAN) Beginning Cash Position : kr9.70 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Genetic Analysis AS Beginning Cash Position?

Genetic Analysis AS's Beginning Cash Position for the quarter that ended in Dec. 2024 was kr9.70 Mil.

Genetic Analysis AS's quarterly Beginning Cash Position declined from Jun. 2024 (kr11.56 Mil) to Sep. 2024 (kr6.97 Mil) but then increased from Sep. 2024 (kr6.97 Mil) to Dec. 2024 (kr9.70 Mil).

Genetic Analysis AS's annual Beginning Cash Position declined from Dec. 2022 (kr46.81 Mil) to Dec. 2023 (kr25.32 Mil) and declined from Dec. 2023 (kr25.32 Mil) to Dec. 2024 (kr16.29 Mil).


Genetic Analysis AS Beginning Cash Position Historical Data

The historical data trend for Genetic Analysis AS's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Analysis AS Beginning Cash Position Chart

Genetic Analysis AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beginning Cash Position
Get a 7-Day Free Trial 4.01 24.18 46.81 25.32 16.29

Genetic Analysis AS Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.77 16.29 11.56 6.97 9.70

Genetic Analysis AS Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


Genetic Analysis AS Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Genetic Analysis AS's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Genetic Analysis AS Business Description

Traded in Other Exchanges
Address
Ulvenveien 80, Oslo, NOR, 0581
Genetic Analysis AS is a research-driven diagnostic company dedicated to delivering innovative diagnostic solutions to the growing human microbiota market. It is providing a CE-marked gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients.

Genetic Analysis AS Headlines

No Headlines